Clinical trials
Breast Neoplasms trials in Austria with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 4 |
| Completed | 4 |
| Recruiting | 4 |
| Unknown status | 3 |
| Withdrawn | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Medical University of Graz | 3 |
| Austrian Breast & Colorectal Cancer Study Group | 2 |
| University Hospital, Basel, Switzerland | 2 |
| Arbeitsgemeinschaft medikamentoese Tumortherapie | 1 |
| ETOP IBCSG Partners Foundation | 1 |
| Fox Chase Cancer Center | 1 |
| Fundacio Clinic Barcelona | 1 |
| Johannes Kepler University of Linz | 1 |
| Klinik Hirslanden, Zurich | 1 |
| Medical University Innsbruck | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 18 |
| Chemotherapy-Related Cognitive Impairment | 1 |
| Cholangiocarcinoma | 1 |
| Colonic Neoplasms | 1 |
| Endometrial Neoplasms | 1 |
| Lung Neoplasms | 1 |
| Lymphedema | 1 |
| Neoplasms | 1 |
| Neoplastic Cells, Circulating | 1 |
| Pancreatic Neoplasms | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.